BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29657242)

  • 1. Diagnosis-related group (DRG)-based case-mix funding system, a promising alternative for fee for service payment in China.
    Zhao C; Wang C; Shen C; Wang Q
    Biosci Trends; 2018 May; 12(2):109-115. PubMed ID: 29657242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical Implications of Case-Based Payment in China: A Systematic Analysis.
    Jin P; Biller-Andorno N; Wild V
    Dev World Bioeth; 2015 Dec; 15(3):134-42. PubMed ID: 24750551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Payment systems and considerations of case mix--are diagnosis-related groups applicable in Japan?
    Kawabuchi K
    Pharmacoeconomics; 2000; 18 Suppl 1():95-110. PubMed ID: 11151315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provider payment reform in China: the case of hospital reimbursement in Hainan province.
    Yip W; Eggleston K
    Health Econ; 2001 Jun; 10(4):325-39. PubMed ID: 11400255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Payment system reform for health care providers in Korea.
    Kwon S
    Health Policy Plan; 2003 Mar; 18(1):84-92. PubMed ID: 12582111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a mandatory DRG payment system in South Korea: Analysis of multi-year nationwide hospital claims data.
    Choi JW; Kim SJ; Park HK; Jang SI; Kim TH; Park EC
    BMC Health Serv Res; 2019 Oct; 19(1):776. PubMed ID: 31666066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case-mix payment in Japanese medical care.
    Okamura S; Kobayashi R; Sakamaki T
    Health Policy; 2005 Nov; 74(3):282-6. PubMed ID: 16226139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Korean Diagnosis-Related Groups payment system on the outcomes of adenotonsillectomy: A single center experience.
    Kwak SH; Kim JH; Kim DH; Kim JM; Byeon HK; Kim WS; Koh YW; Kim SH; Choi EC
    Auris Nasus Larynx; 2018 Jun; 45(3):504-507. PubMed ID: 28756097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of DRG payment on the length of stay and the number of outpatient visits after discharge for caesarean section during 2004-2007].
    Shon C; Chung S; Yi S; Kwon S
    J Prev Med Public Health; 2011 Jan; 44(1):48-55. PubMed ID: 21483223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Payment Reform Pilot In Beijing Hospitals Reduced Expenditures And Out-Of-Pocket Payments Per Admission.
    Jian W; Lu M; Chan KY; Poon AN; Han W; Hu M; Yip W
    Health Aff (Millwood); 2015 Oct; 34(10):1745-52. PubMed ID: 26438752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of DRG Payment in France: issues and recent developments.
    Or Z
    Health Policy; 2014 Aug; 117(2):146-50. PubMed ID: 24962536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Has DRG payment influenced the technical efficiency and productivity of diagnostic technologies in Portuguese public hospitals? An empirical analysis using parametric and non-parametric methods.
    Dismuke CE; Sena V
    Health Care Manag Sci; 1999 May; 2(2):107-16. PubMed ID: 10916607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in patient routine costliness in U.S. psychiatric facilities.
    Cromwell J; Drozd EM; Gage B; Maier J; Richter E; Goldman HH
    J Ment Health Policy Econ; 2005 Mar; 8(1):15-28. PubMed ID: 15870482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing government and market failures with payment incentives: Hospital reimbursement reform in Hainan, China.
    Yip W; Eggleston K
    Soc Sci Med; 2004 Jan; 58(2):267-77. PubMed ID: 14604613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does an economic incentive affect provider behavior? Evidence from a field experiment on different payment mechanisms.
    Xi X; Wang E; Lu Q; Chen P; Wo T; Tang K
    J Med Econ; 2019 Jan; 22(1):35-44. PubMed ID: 30351230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of flat-rate payment in radiation oncology. German experience with disease-related groups for inpatient funding in radiation oncology].
    Glocker S; Loskamp N; Bamberg M; Roeder N
    Strahlenther Onkol; 2006 Jun; 182(6):305-11. PubMed ID: 16703284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling individual health care expenditures in China: Evidence to assist payment reform in public insurance.
    Shi J; Yao Y; Liu G
    Health Econ; 2018 Dec; 27(12):1945-1962. PubMed ID: 30044018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competition policy for health care provision in Norway.
    Brekke KR; Straume OR
    Health Policy; 2017 Feb; 121(2):134-140. PubMed ID: 27916434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving towards universal health insurance in China: performance, issues and lessons from Thailand.
    Li C; Yu X; Butler JR; Yiengprugsawan V; Yu M
    Soc Sci Med; 2011 Aug; 73(3):359-66. PubMed ID: 21733610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk contracting and operational capabilities in large medical groups during national healthcare reform.
    Mechanic RE; Zinner D
    Am J Manag Care; 2016 Jun; 22(6):441-6. PubMed ID: 27355812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.